Drug intelligence / Profile preview

oxeridine

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Oral, Parenteral (injection)

Overview

Oxeridine is an opioid analgesic drug that was developed in the mid-20th century. It is structurally related to pethidine (meperidine) and functions as a synthetic opioid. Like other opioids, it acts primarily as an agonist at the mu-opioid receptor, producing analgesia and sedation. There is limited information on its clinical use or approval status, and it does not appear to be widely marketed or used in current medical practice.

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxeridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxeridine.

Explore the full profile